Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from biotechnology

Strategic Decision-Making in Complex Clinical Development Programs

Clinical development decisions made before a study begins can have consequences throughout the entire research program.

inkl

Global Market: China stocks steady as property shares offset Biotech, chip losses

Chinese stocks were largely steady on Friday as gains in property shares offset losses in biotechnology and semiconductor stocks. The Shanghai Composite edged up 0.1%, while the CSI300 slipped 0.1%. Hong Kong equities advanced, supported by Wall Street gains and Nvidia’s upbeat outlook, which boosted global AI sentiment.

The Economic Times

Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe?

Symbiotec Pharmalab's IPO saw robust investor demand, with the issue subscribed 1.85 times. The company aims to raise Rs 1,757 crore through a fresh issue and offer for sale. Its shares are currently trading at a significant grey market premium, indicating listing gain potential.

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Symbiotec Pharmalab’s Rs 1,757 crore IPO opens with GMP hinting at 41% upside. Should you bid?

Symbiotec Pharmalab IPO GMP: Symbiotec Pharmalab’s Rs 1,757 crore IPO opened August 24, with a Rs 938–988 price band and 41% grey-market premium. The issue combines fresh shares and an OFS, while proceeds will partly repay debt. Its specialised API manufacturing, regulatory approvals and biotechnology capabilities offer investors exposure to…

The Economic Times

IIT Delhi engineer develops fridge that runs without truck engine, cuts cooling costs by 75%

A post on X has highlighted Yotuh Energy, a company co-founded by IIT Delhi biotechnology graduate Shaivee Malik, which has developed a battery-powered refrigeration system for transport vehicles. The technology works independently of truck engines, can run for six to eight hours and is claimed to cut refrigeration costs by…

The Economic Times

Spider Silk Is Being Tested as Surgical Sutures, Wound Dressings, and Biomedical Protein Material

The thread that outperforms steelA dragline silk thread spun by Nephila pilipes, the giant golden orb-weaver found across South and Southeast Asia, has a tensile strength of roughly 1.3 gigapascals, stronger than high-grade steel at a fraction of the weight. That single biological fact is what has made spider silk…

Times Life

Horseshoe Crab Blood Powers Every Vaccine and Injection You Have Ever Been Given

The blue blood that guards every hospital on EarthHorseshoe crab blood is blue. Not metaphorically, literally blue, because it uses copper-based hemocyanin to carry oxygen instead of the iron-based hemoglobin that makes human blood red. But the colour is not why the biomedical industry harvests roughly 600,000 horseshoe crabs every…

Times Life

Read news from The Economist, FT, and more,
with one subscription

The use of AI in biotechnology is changing faster than the rules governing either technology

The recent announcement of novel, viable viruses created by artificial intelligence (AI) was celebrated as a major advance in the fight against antibiotic resistance. But it also raised urgent concerns about regulation.

The Conversation

Congressional Panel Says the United States Is Losing Its Lead on Rare Disease Cures

A bipartisan congressional advisory commission identified four barriers keeping rare disease therapies from patients and urged an all-of-government response.

Medical Daily

At-home STI test pulled from Australian shelves after failing to detect infections

Exclusive: TGA finds Touch Biotechnology test for chlamydia and gonorrhoea ‘is not reliable’ and has affected an unspecified number of people

The Guardian - AU

6 Ayurvedic Herbs With Real Clinical Evidence: Ashwagandha, Turmeric, and More

Ashwagandha (Withania somnifera)The most clinically studied adaptogen in the Ayurvedic pharmacopoeia, ashwagandha has accumulated enough trial data to move beyond wellness-counter claims. A 2019 randomised, double-blind, placebo-controlled trial published in Medicine found that 240 mg of standardised ashwagandha root extract daily reduced serum cortisol by 23% over 60 days. Participants…

Times Life

Eli Lilly Changed Depression Care With Prozac. Now It's Betting on Psychedelics with AtaiBeckley Acquisition

Eli Lilly is making its biggest move yet into the rapidly evolving field of psychedelic medicine, acquiring clinical-stage biotechnology company AtaiBeckley in a deal valued at up to $3.8 billion.

International Business Times

NITI Aayog roadmap targets USD 691 bn bioeconomy by 2035; Jitendra Singh says India ready to lead biotech revolution

India's bioeconomy can reach USD 691 billion by 2035, creating millions of high-value jobs. The nation aims to become a top global biotechnology power, driving future growth. A roadmap proposes six National BioMissions and a significant growth fund for development. Talent development, including engineering biology courses, is deemed critical for…

The Economic Times

'The thing that's amazing to me is this was 3D-printed': Pentagon's SciTech supremo describes future of warfare where projectiles are made up of coconut husks and coffee grounds

The Ukraine war has fundamentally changed the Pentagon's science chief's understanding of the role of AI and biotechnology in future conflicts

TechRadar

Get all your
news in one place.

100's of premium titles.
One news app.

inkl

Canada Clean Room Solutions for Controlled Testing

Manufacturers working in pharmaceutical, biotechnology, healthcare, and research sectors depend on controlled environments every day. A properly designed Canada clean room helps reduce contamination and supports consistent production quality. These facilities maintain strict limits for airborne particles, temperature, and humidity. As regulations continue to evolve, controlled spaces have become essential…

MarketBeat

The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch.

The iShares Nasdaq Biotechnology ETF (IBB) is trading just 1.47% below its 52-week high, signaling a potential multi-year sector breakout.

Euronews

EU ministers reach consensus on Biotech Act directive

Amid Europe’s push to catch up in the biotechnology field, the EU health ministers agreed how to tweak rules on modified micro-organisms (GMMs) and the processing of organs.

The Economic Times

Karnataka explores biotech financing framework, AI-led innovation to support sector growth

Karnataka is developing a dedicated support framework for its biotechnology sector, encompassing funding, mentoring, and regulatory guidance to boost startups and growth capital access. Key focus areas for the next phase of growth include AI-enabled biotechnology and biomanufacturing, aiming to strengthen the state's innovation and investment ecosystem.

Get all your
news in one place.

100's of premium titles.
One news app.

AAP

Angel Yeast Releases 2025 Sustainability Report as Company Marks 40th Anniversary

SHANGHAI, June 13, 2026 /PRNewswire/ -- Angel Yeast (SSE: 600298), one of the world's leading yeast manufacturers, recently marked its 40th anniversary with the release of the 2025 Sustainability Report. Structured around four key themes—Stable Development, Strong Momentum, Green Ecosystem, and Warm Care—the report outlines the company's performance in food…

Euronews

Is it possible to rejuvenate damaged human cells? US biotech firm tests new gene therapy

A US biotechnology company has tested a gene therapy designed to reverse ageing in humans for the first time.

AAP

Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)

SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of positive topline results from its Phase II randomized, double-blind, placebo-controlled trial of CG2001 at the 14th World Congress for Hair Research (WCHR) in Seoul, South…

MarketBeat

argenx Touts VYVGART Growth, 50,000-Patient Goal at William Blair Conference

argenx (NASDAQ:ARGX) Chief Financial Officer Karl Gubitz told investors at the 46th Annual William Blair Growth Stock Conference that the biotechnology company remains focused on revenue growth, profitability and execution as it expands the VYVGART franchise and advances additional pipeline assets.

Euronews

Tech giants warn AI safety gaps could hand bioweapons to bad actors

Synthetic DNA can be used for vaccines, but it can also create bioweapons. Tech giants and biotechnology experts are asking for stronger regulation.

MarketBeat

Aclaris Therapeutics Maps Busy Pipeline Calendar, Plans Phase 2 Asthma Trial for ATI-052

Aclaris Therapeutics (NASDAQ:ACRS) executives outlined a busy clinical calendar for the biotechnology company during a fireside chat at the Jefferies 2026 Global Healthcare Conference, highlighting upcoming readouts across its immunology pipeline and a planned Phase 2 asthma study for its lead bispe

AAP

MEDIPOST Secures FDA Agreement on Single Pivotal Phase 3 Study with Confirmatory Evidence BLA Filing Strategy for CARTISTEM® in the U.S.

SEOUL, South Korea, June 4, 2026 /PRNewswire/ -- MEDIPOST, a fully integrated commercial stage cell therapy biotechnology company, announced today that it has secured the FDA's agreement to conduct a single pivotal Phase 3 study for CARTISTEM® in the U.S. This milestone marks a significant step forward in MEDIPOST's mission…

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

South and Southeast Asia

11 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.